Accessibility Menu
 
Orthocell logo

Orthocell

(ASX) OCC

Current Price$0.91
Market Cap$238.75M
Since IPO (2014)+144%
5 Year+69%
1 Year-44%
1 Month+12%

Orthocell Financials at a Glance

Market Cap

$238.75M

Revenue (TTM)

$15.73M

Net Income (TTM)

$15.73M

EPS (TTM)

$-0.05

P/E Ratio

-17.29

Dividend

$0.00

Beta (Volatility)

0.12 (Low)

Price

$0.91

Volume

412,906

Open

$0.91

Previous Close

$0.90

Daily Range

$0.91 - $0.94

52-Week Range

$0.70 - $1.67

OCC News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Orthocell

Industry

Biotechnology

CEO

Paul Frederick Anderson

Headquarters

Murdoch, WA 6150, AU

OCC Financials

Key Financial Metrics (TTM)

Gross Margin

37%

Operating Margin

-2%

Net Income Margin

-1%

Return on Equity

-41%

Return on Capital

-31%

Return on Assets

-21%

Earnings Yield

-5.78%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$238.75M

Shares Outstanding

271.31M

Volume

412.91K

Avg. Volume

414.59K

Financials (TTM)

Gross Profit

$4.80M

Operating Income

$13.98M

EBITDA

$13.43M

Operating Cash Flow

$8.68M

Capital Expenditure

$359.06K

Free Cash Flow

$9.04M

Cash & ST Invst.

$28.62M

Total Debt

$576.89K

Orthocell Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$5.42M

+111.8%

Gross Profit

$1.06M

-40.9%

Gross Margin

19.57%

N/A

Market Cap

$238.75M

N/A

Market Cap/Employee

$6.45M

N/A

Employees

37

N/A

Net Income

$5.21M

+0.3%

EBITDA

$8.32M

-50.7%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Net Cash

$43.53M

+130.8%

Accounts Receivable

$5.23M

+507.6%

Inventory

$1.57M

+42.3%

Long Term Debt

$650.37K

+5.5%

Short Term Debt

$185.42K

+29.5%

Return on Assets

-20.87%

N/A

Return on Invested Capital

-31.42%

N/A

Free Cash Flow

$9.09M

-74.9%

Operating Cash Flow

$8.98M

-87.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ARX.AXAroa Biosurgery Limited
$0.62-1.59%
MVF.AXMonash IVF Group Limited
$0.74+1.37%
SPL.AXStarpharma Holdings Limited
$0.70-3.42%
AVR.AXAnteris Technologies Ltd
$8.13+5.52%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$12.91+0.04%
SOFISoFi Technologies
$16.10+0.04%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.63+0.10%
MARAMara Holdings
$11.99+0.12%

Questions About OCC

What is the current price of Orthocell?

Orthocell is trading at A$0.91 per share.

What is the 52-week range for Orthocell?

Over the past 52 weeks, Orthocell has traded between A$0.70 and A$1.67.

How much debt does Orthocell have?

As of the most recent reporting period, Orthocell reported total debt of $576,895.

How much cash does Orthocell have on hand?

Orthocell reported $28.62M in cash and cash equivalents in its most recent financial results.

What is Orthocell’s dividend yield?

Orthocell does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.